Stem cell transplant confers superior and long-lasting clinical benefits compared to conventional treatment with Cytoxan cyclophosphamide in people with…
Ana Pena, PhD
Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
The cytokines IL-1 and IL-17 seem to act together to induce fibrosis and inflammation in skin and organs…
Increased Heart Stiffness May Predict Worse Prognosis in Systemic Sclerosis Patients, Study Suggests
Patients with systemic sclerosis (SSc) are more likely to experience stiffness in the…
High protein levels in the urine, poor kidney function, and high blood pressure at the time of systemic…
High levels of a blood protein called CC16 predict a higher likelihood of lung disease worsening in patients…
Treatment with iloprost using a portable pump is efficient, safe, and more convenient for the treatment of …
Using immunosuppressive therapy to treat interstitial lung disease (ILD) associated with scleroderma (SSc) should be done carefully and with close monitoring,…